CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

DOXOFYLLINE FOR INJECTION, 0.1g

DOXOFYLLINE FOR INJECTION, 0.1g

Product Description

Suitable for Dyspnea due to bronchial asthma, chronic bronchitis and other bronchospasm .

AZ Pharmaceutical Group Limited

CN
2017

On CPHI since

Compare Add to favorites Added to favorites

Categories

Specifications

Selling Points
Prompt Delivery; Quality Service
Supplied from

China
Measured In
piece

Sales Markets

Middle East Region (e.g. UAE)
Oceania
North America (USA, Canada)
Africa
Central America (e.g. Mexico)
East Asia (e.g. China, Japan, Korea)
Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
South America (e.g. Brazil, Colombia)
South Asia (e.g. India, Pakistan, Sri Lanka)
South East Asia (e.g. Thailand, Philippines, Singapore)

AZ Pharmaceutical Group Limited

CN
2017

On CPHI since

Compare Add to favorites Added to favorites

More Products from AZ Pharmaceutical Group Limited (2)

Product DAPTOMYCIN FOR INJECTION, 0.5g

For treatment of bloodstream infection (bacteremia) associated with right infective endocarditis caused by Staphylococcus aureus(including methicillin sensitivity and methicillin resistance).

Compare
Product LEVOFLOXACIN MESYLATE FOR INJECTION

strength 0.2g, 0.3g

It suitable for moderate or severe infections caused by sensitive bacterial, including respiratory system infection, acute bronchitis, acute exacerbation of chronic bronchitis, diffuse bacterial bronchitis, bronchiectasis, pneumonia, tonsillitis,etc.

Compare